AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $70,447,000 | +13.2% | 2,044,893 | -45.1% | 0.01% | 0.0% |
| Q2 2020 | $62,247,000 | +96.2% | 3,725,138 | +69.3% | 0.01% | +66.7% |
| Q1 2020 | $31,734,000 | -56.9% | 2,200,720 | -0.1% | 0.00% | -40.0% |
| Q4 2019 | $73,702,000 | +105.0% | 2,202,022 | +28.2% | 0.01% | +66.7% |
| Q3 2019 | $35,956,000 | -13.0% | 1,717,116 | -13.5% | 0.00% | 0.0% |
| Q2 2019 | $41,344,000 | -11.6% | 1,985,774 | -5.1% | 0.00% | -25.0% |
| Q1 2019 | $46,771,000 | +2.5% | 2,092,641 | +9.7% | 0.00% | 0.0% |
| Q4 2018 | $45,642,000 | -5.6% | 1,908,094 | +7.6% | 0.00% | 0.0% |
| Q3 2018 | $48,373,000 | -24.1% | 1,773,162 | -25.2% | 0.00% | -20.0% |
| Q2 2018 | $63,740,000 | +8.3% | 2,370,299 | +28.2% | 0.01% | 0.0% |
| Q1 2018 | $58,842,000 | +27.3% | 1,848,682 | +51.2% | 0.01% | +25.0% |
| Q4 2017 | $46,227,000 | +99.5% | 1,222,280 | +30.8% | 0.00% | +100.0% |
| Q3 2017 | $23,172,000 | +3.7% | 934,735 | -14.0% | 0.00% | 0.0% |
| Q2 2017 | $22,351,000 | +19.8% | 1,087,320 | +26.6% | 0.00% | 0.0% |
| Q1 2017 | $18,663,000 | +58.4% | 858,891 | +49.1% | 0.00% | +100.0% |
| Q4 2016 | $11,782,000 | +104.8% | 576,147 | +50.5% | 0.00% | 0.0% |
| Q3 2016 | $5,752,000 | +50.1% | 382,875 | +8.1% | 0.00% | – |
| Q2 2016 | $3,831,000 | +78.5% | 354,062 | +123.6% | 0.00% | – |
| Q1 2016 | $2,146,000 | -20.2% | 158,344 | +8.6% | 0.00% | – |
| Q4 2015 | $2,690,000 | -12.6% | 145,748 | +19.9% | 0.00% | – |
| Q3 2015 | $3,077,000 | – | 121,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|